| INTRODUCTION
Periodontitis is one of the most widespread inflammatory diseases in humans and the main pathogenic cause of adult tooth loss, 1 as it causes the destruction of supporting structures of the teeth, including the periodontal ligament, bone and gingival tissues.
Although a variety of surgical procedures, including grafting materials, growth factors, 2, 3 and barrier membranes, are used to regenerate lost periodontal tissues, the current challenge faced by clinicians is the complete, reliable and reproducible regeneration of periodontal tissues.
Slightly active inflammation is generally recognized to promote local vasodilatation and attraction, as well as the activation of neutrophils, macrophages and mast cells at early stages of inflammation.
However, our recent studies showed that tumor necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ) produced by proinflammatory T cells may inhibit bone repair and remodeling. 4 Intriguingly, the topical administration of aspirin is capable of inhibiting TNF-α and IFN-γ production, improving calvarial bone repair in rodents and miniature pigs. 5 Compared to systemic infusion of regulatory T cells, the topical administration of aspirin has more advantages from the safety aspect, as aspirin has been used as a non-steroidal anti-inflammatory drug for decades and has a known side-effect profile. 6, 7 The next critical step is to determine a suitable scaffold and delivery system to carry and release aspirin/salicylic acid at the site of bone repair. Choukroun's platelet-rich fibrin (PRF) is a second-generation platelet concentrate including high amounts of platelets, growth factors, leukocyte cytokines and fibrin membrane. PRF has the ability to proliferate fibroblasts and increase collagen synthesis 8 and has been widely used to improve the repair and regeneration of soft and hard tissues after various periodontal surgical procedures. [9] [10] [11] [12] In the present study, we investigated whether PRF is a suitable scaffold for delivering aspirin locally, and we hypothesized that the PRF/aspirin complex provides an ideal approach for functional periodontal tissue regeneration. We established the periodontal bone defect model in rats and analyzed the capability of the PRF/aspirin complex to promote periodontal bone repair. The data would provide a new strategy for reducing local inflammation and improving bone regeneration in periodontal defect therapy in rats.
| MATERIAL AND METHODS

| Animals
A total of 25 female Sprague-Dawley rats (8 weeks of age) were used in the present study; 15 for alveolar bone defect surgery and 10 for the preparation of PRF. The rats were obtained from the Institute of Animal Science of Vital River Co., Ltd. (Beijing, China). They were fully barrier-reared with free access to water and a regular supply of food. The study was conducted according to the approved guidelines set by the Animal Ethics Committee of the School of Stomatology, Capital Medical University (Beijing, China). All animal experiments were performed using the institutionally approved protocols for the use of animals in research (Capital Medical University no. 2012-x-53).
| Preparation of platelet-rich fibrin and plateletrich fibrin/aspirin complex
To obtain PRF, blood was collected in a syringe by cardiac puncture of donor animals without the addition of anticoagulant; 2.7 mL blood with 30 μL dimethyl sulfoxide (Sigma-Aldrich, St. Louis, MO, USA) and 270 μL phosphate-buffered saline (PBS; Hyclone, Logan, UT, USA)
were mixed and centrifuged at 2748 g for 10 minutes and the PRF membrane immediately withdrawn from the tube and separated from the remaining blood.
To obtain the PRF/aspirin complex, 300 μg aspirin (Sigma-Aldrich) was dissolved in 30 μL dimethyl sulfoxide as a hydrotropy agent and diluted in 270 μL PBS before mixing with 2.7 mL of rat blood. The final concentration of aspirin in blood is 100 μg/mL. The blood samples with aspirin were centrifuged at 2748 g for 10 minutes. The PRF/aspirin complexes were immediately withdrawn from the tube and separated from the remaining blood.
| Platelet-rich fibrin and platelet-rich fibrin/ aspirin complex characterization
For scanning electron microscopy (SEM), samples of PRF and the PRF/aspirin complex were fixed using 3% glutaraldehyde in PBS (pH 7.4) for 24 hours. After removal of the glutaraldehyde solution, the PRF and PRF/aspirin complex were dehydrated in a series of ethanol solutions and dried. The topographies of the samples were observed under a scanning electron microscope (Hitachi, Tokyo, Japan) at 10-25 kV.
| Evaluation of the release of aspirin from the platelet-rich fibrin/aspirin complex
To evaluate the kinetics of aspirin release from the PRF/aspirin complex, we analyzed the concentration of aspirin and its product of metabolism, salicylic acid, at different time points: 0. Chromatographic separation was achieved using an Acclaim™ C18
column (150×4.6 mm, 5 μm particles; Thermo Scientific). An isocratic elution consisting of acetonitrile and water (28:72) (both contain 0.05% trifluoroacetic acid) was used. The flow rate was 1.0 mL/min, the injection volume was 20 μL and the oven temperature was set at 30°C. Aspirin, salicylic acid and tinidazole were measured at 277 nm using a diode array detector.
Stock solutions of aspirin and salicylic acid were prepared by dissolving accurately weighed standard compounds in acetonitrile (containing 0.1% trifluoroacetic acid to avoid hydrolysis of aspirin) while IS was dissolved in water. A series of calibration samples of 1, 2.5, 5, 10, 25 and 50 μg/mL for both aspirin and salicylic acid containing 2 μg/ mL IS were prepared. All solutions were stored at −80°C before use.
| Isolation of human periodontal ligament mesenchymal cells
The and then incubated at 37°C in 5% CO 2 . Colony-forming efficiency was assessed on day 14. Aggregates of 50 or more cells were scored as colonies.
| Cell counting
Cells were seeded into six-well plates(1. 
| In vitro wound closure
Cells (1.5×10 5 cells/well) were plated in six-well plates for 24 hours, wounded by scratching with a 1000 μL pipette tip, cellular debris was removed by washing with PBS and then incubated with α-minimal Eagle's medium without fetal bovine serum. PRF or the PRF/aspirin complex were seeded in the wells. The width of the scratch was determined microscopically immediately after creation and 24 hours later by using a phase-contrast microscope (Olympus, Tokyo, Japan). The wounded areas were quantified as wound width by Photoshop CS5.
| Establishment of an alveolar bone defect model in rats
Three separate cohorts of rats (n=15) were studied using the same general experimental design for periodontal bone defects. The animals were anesthetized before raising full-thickness buccal flaps following sulcular incisions on the first maxillary molar ( Figure S1A ,B).
The alveolar bone between the inferior buccal mesial root and anterior buccal distal root was removed using a surgical bur and the buccal middle root extracted ( Figure S1C ). The depth and height of the bone defect were each 2 mm. A notch-shaped mark was made on the root surface at the floor of the defect inferior to the buccal mesial root ( Figure S1F ). Two alveolar defects were created in each animal, for a total of 30 alveolar defects.
| Implantation
The rats were randomly assigned to three different treatment groups.
In the control group, the alveolar bone defect was covered by the mucoperiosteal flap and no treatment applied. In the PRF and PRF/ aspirin complex groups, the alveolar bone defect was refilled with PRF or the PRF/aspirin complex, respectively ( Figure S1D ). After the operation, the mucoperiosteal flap was sutured using 6-0 silk ligament ( Figure S1E ).
| Stereoscopic microscopy and micro-computed tomography
Three months after implantation, all animals were killed using CO 2 .
The maxillary bones were dissected and the soft tissues removed. The samples were observed with a stereoscopic microscope (Olympus). 
| Quantitative and histological evaluation of bone regeneration
After radiological analysis, the maxillary samples were decalcified and embedded in paraffin. Sections (5 μm thick) from the embedded specimen were stained with hematoxylin and eosin. Each section was analyzed semi-quantitatively using a histomorphometric technique. The new bone area was calculated from the bottom of the bone defect to the coronal extension of alveolar bone by two examiners who were blinded to the experimental condition. The mean values for the newly formed bone were determined.
Masson's trichrome staining was performed according to the man- The sections were placed in phosphomolybdic-phosphotungstic acid solution until the collagen was decolorized, before they were transferred directly (without rinse) to the aniline blue solution and washed with 1% acetic acid.
| Statistical analysis
The data were analyzed using SPSS 13 statistical software. Data were reported as the mean±standard deviation or standard error of the mean. A significance of P≤.05 was determined using the unpaired Student t test or one-way ANOVA. At least three biological replicates were used unless otherwise stated.
| RESULTS
| Structures of platelet-rich fibrin and plateletrich fibrin/aspirin complex
Macroscopic observations showed no difference between the PRF and PRF/aspirin complex based on appearance; both of them were soft, light yellow and gel-like ( Figure 1A,B) . SEM showed that PRF had an irregular grid-like arrangement of loose fibers and pores ( Figure 1C ).
In contrast, the PRF/aspirin complex consisted of compact clusters of fibers, and more platelets and leukocytes were observed under high magnification ( Figure 1D ).
| Capability of sustained-release from plateletrich fibrin/aspirin complex
For the PRF/aspirin complex at 37°C, the concentration of aspirin in solution slowly increased during the first 2 hours, and then decreased. The peak concentration was 25.4 μg/mL in diluted solution.
The concentration of salicylic acid quickly reached 34.3 μg/mL in the first hour, and then slowly increased. At 48 hours, the concentration of salicylic acid was 71.2 μg/mL. The total concentration of released aspirin and salicylic acid in stock solution was 83.5 μg/mL. The peak concentration occurred 4 hours after transplantation ( Figure 1E ).
| Cell proliferation and migration
To investigate whether the PRF and PRF/aspirin complex influences the growth of periodontal ligament mesenchymal cells, cells were cocultured with PRF or PRF/aspirin for 24 hours. The migration of cells was measured and PRF treatment showed less migration ability than PRF/aspirin treatment (Figure 2A-D) . In the PRF group, the width of cell migration/width of scratch was 75.78% and in the PRF/aspirin group was 57.44% (P<.01; Figure 2E ).
We tested if periodontal ligament mesenchymal cell proliferation was verified by the viable cell counting method, as cells were Figure 2H ).
| Bone analysis by micro-computed tomography
Twelve weeks post-replantation, macroscopic photographs showed that the bone defects were enlarged in most of the samples in the control group ( Figure 3A) , and the PRF/aspirin complex group had better periodontal bone tissue regeneration than the PRF and Figure 3G ).
The capability of the PRF/aspirin complex to improve bone regeneration was also confirmed by 2D micro-CT images on the coronal and horizontal planes. In coronal plane micro-CT images, the areas of regenerated bone were measured every 0.18 mm from the bottom of the molar pulp chamber to the bottom of the bone defect ( Figure 4A ).
A total of five layers were analyzed ( Figure 4B ). The bone regeneration was much greater in the PRF/aspirin complex group than the PRF and control groups (P<.05; Figure 4C ).
In the horizontal plane, the areas of regenerated bone were measured every 0.18 mm from the anterior lingual mesial root to the posterior distal root ( Figure 5A ). A total of five layers were analyzed ( Figure 5B ). The bone regeneration was greater in the PRF/aspirin complex group than the PRF and defect groups (P<.05; Figure 5C ). Figure 7F ). In control group, there was no bone formation at the defect site ( Figure 7C ).
| DISCUSSION
Periodontitis is a disease of the periodontium, characterized by a loss of connective tissue attachment and support of the alveolar bone. This is also associated with systemic diseases, such as diabetes mellitus and cardiovascular disease. Although guided tissue regeneration and enamel and enhancement of TNF-α signaling, which induces cell apoptosis. 4 The study strategy was to mitigate the host local immune response during alveolar bone repair in periodontitis. Aspirin was chosen as an ideal immune regulator drug for local application. Aspirin is a nonsteroidal anti-inflammatory drug, which acts through the inhibition of cyclo-oxygenase-2 activity and therefore inhibition of prostaglandin synthesis. Our previous studies indicated that aspirin is a feasible and efficient pharmacological approach for activating telomerase activity to avoid replicative senescence and improve stem cell differentiation and immunomodulation. 13, 14 We also confirmed that local application of aspirin decreases inflammation, enhances bone marrow mesenchymal stem cell (MSC) osteogenic capacity and improves calvarial bone defect repair in miniature pigs. 15 Based on these benefits of aspirin, a suitable delivery system should be found out for sustained-release of the drug. Biomaterials have been utilized to control and manipulate the fate of stem cells, leading to high-quality tissue regeneration. In periodontal tissue engineering, the biomaterials play an essential role in the presentation of the physiological niche for MSC migration, colonization and differentiation. Based on the need for a specific bioabsorbable scaffold, PRF possesses a unique advantage as an anti-inflammatory drug delivery carrier. PRF could slowly release a set of growth factors, including platelet-derived growth factor, transforming growth factor-beta 1, insulin-like growth factor, basic fibroblast growth factor and vascular endothelial growth factor. [16] [17] [18] [19] These growth factors could enhance cell proliferation and extracellular matrix synthesis, promoting wound healing and the regeneration of bone tissue. [20] [21] [22] PRF also contains fibrin matrix and provides a 3D network structure for MSC growth and the sealing of wound borders. 8 In this study, PRF was designed to integrate with aspirin as a favorable delivery system in a specific area of periodontal destruction, thereby enhancing the quality of periodontal regeneration in vivo.
We need 3ml blood to prepare PRF. After obtained blood through cardiac puncture, the rats were suffering postpartum hemorrhage, so we used allogeneic PRF and PRF/aspirin complex to transplant. We found that the PRF/aspirin complex has the advantages of both PRF and aspirin, and it is more suitable for mesenchymal cell growth and migration. Moreover, the PRF/aspirin complex can release aspirin in a sustained-release manner and its metabolic product salicylic acid to J.D.). The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.
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